Competing risks of death in younger and older postmenopausal breast cancer patients

AIM: To show a new paradigm of simultaneously testing whether breast cancer therapies impact other causes of death. METHODS: MA.14 allocated 667 postmenopausal women to 5 years of tamoxifen 20 mg/daily ± 2 years of octreotide 90 mg, given by depot intramuscular injections monthly. Event-free surviva...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:World J Clin Oncol
Main Authors: Chapman, Judy-Anne W, Pritchard, Kathleen I, Goss, Paul E, Ingle, James N, Muss, Hyman B, Dent, Susan F, Vandenberg, Ted A, Findlay, Brian, Gelmon, Karen A, Wilson, Carolyn F, Shepherd, Lois E, Pollak, Michael N
Formato: Artigo
Idioma:Inglês
Publicado: Baishideng Publishing Group Inc 2014
Assuntos:
Retrospective Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4259936/
https://ncbi.nlm.nih.gov/pubmed/25493245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v5.i5.1088
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares